CD16 expression on neutrophils predicts treatment efficacy of capecitabine in colorectal cancer patients | BMC Immunology | Full Text

CD16 expression on neutrophils predicts treatment efficacy of capecitabine in colorectal cancer patients | BMC Immunology | Full Text

CD16 expression on neutrophils predicts treatment efficacy of capecitabine in colorectal cancer patients

Early detection of capecitabine-resistance could largely increase overall survival of colorectal cancer (CRC) patients. Previous studies suggested examination of immune cells in peripheral blood would help to ...

Authors:Yu Lu, Yizhou Huang, Lei Huang, Yanjie Xu, Zien Wang, Han Li, Ting Zhang, Ming Zhong, Wei-qiang Gao and Yan Zhang

Citation:BMC Immunology 2020 21:46

Content type:Research article

 

Published on: 8 August 2020

• ViewFull Text
 
• ViewPDF